PharVision Advisers’s NetApp NTAP Stock Holding History

PharVision Advisers’s Portfolio NTAP Stock Details NTAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,473	Closed	-$403K	–	443
2024 Q4	$403K	Buy	+3,473	New	+$424K	0.34%	76

Other funds holding NTAP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's NTAP Position: Q1 2025 in Review

PharVision Advisers sold out of NetApp (NTAP) in Q1 2025, closing a stake of 3,473 shares — an estimated $403K sold.

PharVision Advisers first reported a position in NTAP in Q4 2024 and held it in 1 quarter. The position peaked at $403K in Q4 2024. 828 funds tracked by Wall St. Rank hold NTAP as of Q1 2025.

PharVision Advisers reported no remaining NetApp position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 3,473 NetApp shares in Q1 2025, an estimated $403K.
PharVision Advisers first reported a position in NetApp in Q4 2024 and held it in 1 quarter.
PharVision Advisers's NetApp position peaked at $403K in Q4 2024.
828 funds tracked by Wall St. Rank held NetApp as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.